Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
1,868
INR
|
-1.50%
|
|
+0.78%
|
+4.08%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,888
|
8,393
|
6,861
|
7,616
|
10,895
|
8,216
|
Enterprise Value (EV)
1 |
8,911
|
9,830
|
8,117
|
8,509
|
11,761
|
9,436
|
P/E ratio
|
26.1
x
|
12.8
x
|
9.41
x
|
32.7
x
|
16.7
x
|
9.84
x
|
Yield
|
0.73%
|
1.33%
|
1.02%
|
0.55%
|
1.15%
|
1.87%
|
Capitalization / Revenue
|
1.88
x
|
1.38
x
|
1.18
x
|
2.2
x
|
1.8
x
|
0.99
x
|
EV / Revenue
|
2.43
x
|
1.61
x
|
1.4
x
|
2.46
x
|
1.95
x
|
1.13
x
|
EV / EBITDA
|
17
x
|
7.45
x
|
6.5
x
|
17.1
x
|
11.2
x
|
5.87
x
|
EV / FCF
|
-7.03
x
|
20.8
x
|
17.4
x
|
25.5
x
|
-143
x
|
19.4
x
|
FCF Yield
|
-14.2%
|
4.8%
|
5.76%
|
3.92%
|
-0.7%
|
5.14%
|
Price to Book
|
2.79
x
|
2.7
x
|
2.03
x
|
2.01
x
|
2.25
x
|
1.4
x
|
Nbr of stocks (in thousands)
|
5,586
|
5,586
|
5,586
|
5,586
|
5,586
|
5,586
|
Reference price
2 |
1,233
|
1,503
|
1,228
|
1,363
|
1,950
|
1,471
|
Announcement Date
|
8/18/18
|
7/13/19
|
9/1/20
|
8/21/21
|
8/18/22
|
8/2/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,666
|
6,096
|
5,793
|
3,455
|
6,039
|
8,338
|
EBITDA
1 |
523.9
|
1,319
|
1,249
|
498
|
1,049
|
1,607
|
EBIT
1 |
424.7
|
1,178
|
1,070
|
303.4
|
848.3
|
1,388
|
Operating Margin
|
11.58%
|
19.32%
|
18.47%
|
8.78%
|
14.05%
|
16.65%
|
Earnings before Tax (EBT)
1 |
350.2
|
1,013
|
935.2
|
255.4
|
842.4
|
1,128
|
Net income
1 |
264
|
657.4
|
729.4
|
233.1
|
654
|
834.8
|
Net margin
|
7.2%
|
10.78%
|
12.59%
|
6.75%
|
10.83%
|
10.01%
|
EPS
2 |
47.27
|
117.7
|
130.6
|
41.74
|
117.1
|
149.4
|
Free Cash Flow
1 |
-1,268
|
471.7
|
467.7
|
333.9
|
-82.35
|
485.4
|
FCF margin
|
-34.6%
|
7.74%
|
8.07%
|
9.66%
|
-1.36%
|
5.82%
|
FCF Conversion (EBITDA)
|
-
|
35.76%
|
37.45%
|
67.04%
|
-
|
30.21%
|
FCF Conversion (Net income)
|
-
|
71.76%
|
64.12%
|
143.23%
|
-
|
58.15%
|
Dividend per Share
2 |
9.000
|
20.00
|
12.50
|
7.500
|
22.50
|
27.50
|
Announcement Date
|
8/18/18
|
7/13/19
|
9/1/20
|
8/21/21
|
8/18/22
|
8/2/23
|
Fiscal Period: March |
2022 Q4
|
---|
Net sales
1 |
1,427
|
EBITDA
1 |
163.3
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
|
-
|
Net margin
|
-
|
EPS
|
-
|
Dividend per Share
|
-
|
Announcement Date
|
6/13/22
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,024
|
1,437
|
1,256
|
894
|
866
|
1,220
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.863
x
|
1.09
x
|
1.006
x
|
1.794
x
|
0.8259
x
|
0.7591
x
|
Free Cash Flow
1 |
-1,268
|
472
|
468
|
334
|
-82.4
|
485
|
ROE (net income / shareholders' equity)
|
11.7%
|
23.5%
|
22.4%
|
6.49%
|
15.1%
|
15.6%
|
ROA (Net income/ Total Assets)
|
5.57%
|
12.6%
|
11.2%
|
3.19%
|
7.78%
|
10.5%
|
Assets
1 |
4,740
|
5,203
|
6,487
|
7,303
|
8,409
|
7,941
|
Book Value Per Share
2 |
442.0
|
558.0
|
606.0
|
680.0
|
867.0
|
1,050
|
Cash Flow per Share
2 |
1.180
|
0.4600
|
0.7200
|
27.70
|
2.860
|
9.840
|
Capex
1 |
1,195
|
478
|
374
|
175
|
477
|
493
|
Capex / Sales
|
32.59%
|
7.84%
|
6.45%
|
5.08%
|
7.9%
|
5.91%
|
Announcement Date
|
8/18/18
|
7/13/19
|
9/1/20
|
8/21/21
|
8/18/22
|
8/2/23
|
|
1st Jan change
|
Capi.
|
---|
| +4.08% | 125M | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | +6.39% | 11.24B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B |
Diversified Chemicals
|